AFP
The Prime Minister of the Czech Republic, Andrei Babisch, announced that his country wants the Russian “Sputnik V” vaccine to be registered with the European Medicines Agency.
read more
In a video message to his countrymen on Facebook, Babisch said: “We want to register Sputnik V with the European Medicines Agency. The question is whether or not the manufacturers of Sputnik V will apply for registration, due to the lack of sufficient numbers of this vaccine (against the backdrop of increased demand) The question also revolves around whether our state institute for drug control will deal with this issue (issuing a permit for the use of the Russian vaccine in the Czech Republic), if the manufacturers of Sputnik V do not apply for registration with the European Medicines Agency.
Babish revealed that he is receiving letters from his citizens that include recommendations to the authorities to purchase the “Sputnik V” vaccine for use in the Czech Republic, because the Russian vaccine is safe and has proven highly effective, stressing: “We will look into this issue. We need vaccines now, in February, March and April.”
The Prime Minister of the Czech Republic pointed out that his country is supposed to receive in the second quarter of this year 10.4 million doses of various vaccines, indicating that the current authorities in the Czech Republic, which aspire to vaccinate more than 100,000 people per day, suffer from an acute shortage The vaccine.
And local media had reported earlier that the Czech Ministry of Health had already begun studying legal exits to quickly solve the problem of using Sputnik V in the country, without registering it in advance in the European Union.
In the same regard, the Czech Prime Minister explained that Blah has received 511 710 doses of vaccines so far. 346,439 residents of the country have been vaccinated, of whom 9,1059 people have already received the second dose. 98,598 people have also received the vaccination out of 440,000 citizens over the age of 80.
Czechia imports vaccines produced by the American company “Pfizer” in conjunction with German Biontech, as well as the American company “Moderna” and the Swedish-British company “AstraZeneca”. Because of the problems with producing the Pfizer vaccine, supplies to the Czech Republic have been greatly reduced.
Source: TASS
Source link